Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Scynexis (SCYX) Research & Development (2016 - 2026)

Scynexis filings provide 14 years of Research & Development readings, the most recent being $12.4 million for Q1 2026.

  • On a quarterly basis, Research & Development rose 140.25% to $12.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $29.5 million, a 21.18% increase, with the full-year FY2025 number at $22.3 million, down 15.62% from a year prior.
  • Research & Development hit $12.4 million in Q1 2026 for Scynexis, up from $4.5 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $12.4 million in Q1 2026 to a low of $4.3 million in Q4 2024.
  • Median Research & Development over the past 5 years was $6.8 million (2023), compared with a mean of $7.0 million.
  • Biggest five-year swings in Research & Development: plummeted 59.25% in 2024 and later skyrocketed 140.25% in 2026.
  • Scynexis' Research & Development stood at $7.8 million in 2022, then skyrocketed by 34.87% to $10.6 million in 2023, then plummeted by 59.25% to $4.3 million in 2024, then increased by 5.35% to $4.5 million in 2025, then surged by 171.75% to $12.4 million in 2026.
  • The last three reported values for Research & Development were $12.4 million (Q1 2026), $4.5 million (Q4 2025), and $5.5 million (Q3 2025) per Business Quant data.